Scarica l'app Stockscreener
291.04
0.65%
1.89
Dopo l'orario di chiusura:
291.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Cencora Inc Borsa (COR) Ultime notizie
Cencora (COR) Stock Surpasses Market Gains with Strong PerformanceNews and Statistics - IndexBox
Ex-Dividend Reminder: Cencora, Organon and Esquire Financial Holdings - Nasdaq
Cencora Stock: Analyst Estimates & Ratings - inkl
Wells Fargo raises Cencora stock price target to $354 on strong U.S. Healthcare performance - Investing.com Nigeria
Cencora price target raised to $354 from $337 at Wells Fargo - TipRanks
Will Cencora Inc. stock go up in YEARProduct Launch & Real-Time Sentiment Analysis - newsyoung.net
Stock Analysis | Cencora OutlookMixed Signals as Technicals and Analysts Diverge - AInvest
Investors Still Waiting For A Pull Back In Cencora, Inc. (NYSE:COR) - 富途牛牛
Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap (NYSE:COR) - Seeking Alpha
Cencora Lifts Earnings Outlook After Strong Q3 Performance - MSN
Cencora & The Lash Group Settle Data Breach Litigation for $40 Million - The HIPAA Journal
Cencora (COR) Shares Jump 1.95% as Trading Volume Surges to $530M Ranking 184th in Market Activity - AInvest
3 Reasons Growth Investors Will Love Cencora (COR) - Yahoo Finance
Is It Smart To Buy Cencora, Inc. (NYSE:COR) Before It Goes Ex-Dividend? - simplywall.st
Why You Might Be Interested In Cencora, Inc. (NYSE:COR) For Its Upcoming Dividend - ca.finance.yahoo.com
Published on: 2025-08-10 00:34:30 - metal.it
Cencora, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st
Cencora Rises 2.42% as Trading Volume Slumps to 313th Market Rank - AInvest
Cencora Q3: Growing Specialty Drug Distributions; Initiate At Buy (NYSE:COR) - Seeking Alpha
Can Specialty and GLP-1 Momentum Support Cencora's Q3 Results? - MSN
Cencora, Inc. Reports Strong Q3 2025 Financial Results - The Globe and Mail
Cencora Reports Strong Q3 2025 Financial Results - The Globe and Mail
Cencora: Fiscal Q3 Earnings Snapshot - New Haven Register
Cencora (COR) Reports Q3 Earnings Growth, Maintains US$0.55 Dividend - simplywall.st
Cencora’s Earnings Call: Strong Growth Amid Challenges - TipRanks
Cencora Earnings: Solid Results Illustrate Healthy Demand and Stable Outlook; Shares Fairly Valued - Morningstar
Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook - AOL.com
Cencora Benefits From Strong GLP-1 Sales, Healthy Utilization Trends, and Growing Specialty Assets - Morningstar
Cencora, Inc. SEC 10-Q Report - TradingView
Cencora raises 2025 EPS guidance to $15.85–$16 and narrows outlook as specialty drives growth - MSN
Cencora weakness after earnings ‘overdone,’ says Leerink - TipRanks
COR Q3 Earnings & Revenues Beat Estimates, '25 EPS View Raised - The Globe and Mail
Earnings call transcript: Cencora Inc. beats Q3 2025 expectations, stock dips - Investing.com Nigeria
Transcript : Cencora, Inc., Q3 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Cencora (COR) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance
Cencora Q3 2025 slides: U.S. segment drives 19.8% EPS growth, guidance raised By Investing.com - Investing.com South Africa
Cencora Q3 2025 slides: U.S. segment drives 19.8% EPS growth, guidance raised - Investing.com
Cencora, Inc. Exceeds Expectations with Strong Fiscal Q3 EarningsNews and Statistics - IndexBox
Cencora Inc (COR) Q3 2025 Earnings: EPS of $3.52 Beats Estimates, Revenue Hits $80.7 Billion - GuruFocus
Cencora beats Q3 expectations, raises full-year earnings outlook By Investing.com - Investing.com Australia
Cencora, Inc. Q3 Profit Increases, Beats Estimates - Nasdaq
Cencora beats Q3 expectations, raises full-year earnings outlook - Investing.com
Cencora Inc earnings beat by $0.16, revenue topped estimates - Investing.com South Africa
Cencora’s (NYSE:COR) Q2 Sales Top Estimates - Yahoo Finance
Cencora Earnings Soar Past Estimates as Healthcare Giant Boosts 2025 Profit Outlook - Stock Titan
Cencora's $440M Volume Surge Ranks 281st Amid 0.44% Drop as Liquidity-Driven Gains Outpace Market - AInvest
Mallinckrodt Names Leslie Donato to Board of Directors - BioSpace
Cencora & The Lash Group reach $40M settlement in data breach class action - Claim Depot
1.24%
4.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):